TY - JOUR T1 - Does Telemedicine Reduce health disparities? Longitudinal Evidence during the COVID-19 Pandemic in the US JF - medRxiv DO - 10.1101/2021.03.01.21252330 SP - 2021.03.01.21252330 AU - Ali Roghani AU - Samin Panahi Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/02/2021.03.01.21252330.abstract N2 - Objective The COVID-19 pandemic could be a significant health issue for the elderly population and those with pre-excising chronic condition. In response to the pandemic health care services have increased the use of telehealth medicine. The propose of this study is to examine factors associated with access to telemedicine before and after COVID-19 based on sociodemographic factors and type of chronic disease.Method We have used data from the Research and Development Survey (RANDS) at two different time points Data collection for the first wave occurred between June 9, 2020 and July 6, 2020 (n= 6786), second wave was between August 3, 2020 and August 20, 2020 (n=5972). Three questions have been asked from the participant: 1) did the provider offer telemedicine before the pandemic? 2) does the provider offer telemedicine during the pandemic? And 3) have the participants schedule telemedicine appointments?Result In both waves, 62 % of the participants reported providers did not have telemedicine services prior to the COVID-19 pandemic. However, we found a 22% increase in offering telemedicine in six first month of the COVID-19 pandemic. The finding shows almost no change in providing telemedicine between June and August. The data indicates just a 0.5% and 0.1% increase in accessing telemedicine, and scheduling in August than June, respectively. Patients older than 65 had higher access to telemedicine and had higher scheduling frequencies than other age groups, while they had the lowest access prior to the COVID-19. Blacks had the highest access to telemedicine services than other races (40%). Additionally, females, higher education, and living in metropolitan areas were associated with higher access and scheduling during the pandemic. There was a variation of access and scheduling in different chronic diseases, however, providers offered more remote services for those who diagnosed by diabetes.Conclusion The aim of telemedicine is to reduce disparities in healthcare access. The findings of this study show telemedicine has reduced racial disparities and provided greater accessibility for older groups. However, spatial and educational disparities are still noticeable. Research is necessary to examine how healthcare must address the socioeconomic heterogeneity in telemedicine by avoiding further disparities.Competing Interest StatementThe authors have declared no competing interest.Funding Statementn/aAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research uses public domain data from the Research and Development Survey (RANDS) to administer survey question evaluation and statistical research. RANDS is a continuous range of studies for methodological research at the National Center for Health Statistics (NCHS). The information presented on RANDS survey is based on data collected by commercial vendors, called panels, who agreed to participate in survey in exchange of receiving compensations. The common core measures for the use of RANDS data includes Bureau code of 009.00 and program code of 009:020. For more information you can check this link: https://www.cdc.gov/nchs/covid19/rands/telemedicine.htm#limitationsAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is publicly available: https://www.cdc.gov/rdc/b1datatype/rdcrands.htmTHIS DATA IS AVAILABLE AT: https://www.cdc.gov/nchs/covid19/rands/telemedicine.htm#limitations https://www.cdc.gov/nchs/covid19/rands/telemedicine.htm#limitations ER -